-
Something wrong with this record ?
Interaction of GABAA and GABAB antagonists after status epilepticus in immature rats
P. Mareš, H. Kubová,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
- MeSH
- GABA-A Receptor Antagonists metabolism MeSH
- GABA-B Receptor Antagonists adverse effects metabolism MeSH
- Anticonvulsants therapeutic use MeSH
- Rats MeSH
- Phosphinic Acids adverse effects metabolism MeSH
- Drug Interactions physiology MeSH
- Animals, Newborn MeSH
- Pentylenetetrazole adverse effects MeSH
- Rats, Wistar MeSH
- Status Epilepticus chemically induced drug therapy metabolism MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Among neurotransmitter systems affected by status epilepticus (SE) in adult rats are both GABAergic systems. To analyze possible changes of GABAA and GABAB systems in developing rats lithium-pilocarpine SE was induced at postnatal day 12 (P12). Seizures were elicited by a GABAA antagonist pentylenetetrazol (PTZ) 3, 6, 9, and 13 days after SE (i.e., in P15, P18, P21, and P25 rats), and their possible potentiation by a GABAB receptor antagonist CGP46381 was studied. Pilocarpine was replaced by saline in control animals (lithium-paraldehyde [LiPAR]). Pentylenetetrazol in a dose of 50 mg/kg s.c. elicited generalized seizures in nearly all 15-day-old naive rats and in 40% of 18-day-old ones but not in older animals. After SE, PTZ no longer elicited seizures in these two younger groups, i.e., sensitivity of GABAA system was diminished. The GABAB antagonist exhibited proconvulsant effect in P15 and P18 SE as well as LiPAR rats returning the incidence of PTZ-induced seizures to values of control animals. A decrease in the incidence of minimal clonic seizures was seen in P21 LiPAR animals; these seizures in the oldest group were not affected. Change of the effect from proconvulsant to anticonvulsant (or at least to no action) took place before postnatal day 21. Both SE and LiPAR animals exhibited similar changes but their intensity differed, effects in LiPAR controls were usually more expressed than in SE rats.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028634
- 003
- CZ-PrNML
- 005
- 20210114154523.0
- 007
- ta
- 008
- 210105s2020 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.yebeh.2019.106683 $2 doi
- 035 __
- $a (PubMed)31760199
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Mareš, Pavel $u Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: Pavel.Mares@fgu.cas.cz.
- 245 10
- $a Interaction of GABAA and GABAB antagonists after status epilepticus in immature rats / $c P. Mareš, H. Kubová,
- 520 9_
- $a Among neurotransmitter systems affected by status epilepticus (SE) in adult rats are both GABAergic systems. To analyze possible changes of GABAA and GABAB systems in developing rats lithium-pilocarpine SE was induced at postnatal day 12 (P12). Seizures were elicited by a GABAA antagonist pentylenetetrazol (PTZ) 3, 6, 9, and 13 days after SE (i.e., in P15, P18, P21, and P25 rats), and their possible potentiation by a GABAB receptor antagonist CGP46381 was studied. Pilocarpine was replaced by saline in control animals (lithium-paraldehyde [LiPAR]). Pentylenetetrazol in a dose of 50 mg/kg s.c. elicited generalized seizures in nearly all 15-day-old naive rats and in 40% of 18-day-old ones but not in older animals. After SE, PTZ no longer elicited seizures in these two younger groups, i.e., sensitivity of GABAA system was diminished. The GABAB antagonist exhibited proconvulsant effect in P15 and P18 SE as well as LiPAR rats returning the incidence of PTZ-induced seizures to values of control animals. A decrease in the incidence of minimal clonic seizures was seen in P21 LiPAR animals; these seizures in the oldest group were not affected. Change of the effect from proconvulsant to anticonvulsant (or at least to no action) took place before postnatal day 21. Both SE and LiPAR animals exhibited similar changes but their intensity differed, effects in LiPAR controls were usually more expressed than in SE rats.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a novorozená zvířata $7 D000831
- 650 _2
- $a antikonvulziva $x terapeutické užití $7 D000927
- 650 _2
- $a lékové interakce $x fyziologie $7 D004347
- 650 _2
- $a antagonisté receptorů GABA-A $x metabolismus $7 D058787
- 650 _2
- $a antagonisté receptorů GABA-B $x škodlivé účinky $x metabolismus $7 D058788
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a pentylentetrazol $x škodlivé účinky $7 D010433
- 650 _2
- $a kyseliny fosfinové $x škodlivé účinky $x metabolismus $7 D010721
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a status epilepticus $x chemicky indukované $x farmakoterapie $x metabolismus $7 D013226
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kubová, Hana $u Department of Developmental Epileptology, Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic. Electronic address: Hana.Kubova@fgu.cas.cz.
- 773 0_
- $w MED00005701 $t Epilepsy & behavior : E&B $x 1525-5069 $g Roč. 102, č. - (2020), s. 106683
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31760199 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20210114154520 $b ABA008
- 999 __
- $a ok $b bmc $g 1608969 $s 1119814
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 102 $c - $d 106683 $e 20191121 $i 1525-5069 $m Epilepsy & behavior $n Epilepsy Behav $x MED00005701
- LZP __
- $a Pubmed-20210105